Who owns metformin?

Who owns metformin (the generic drug)?

Metformin is an off-patent generic medicine, so ownership depends on which “metformin” product you mean: the underlying active ingredient is not owned by a single company the way a patented brand is.

Which company owns metformin—brand names vs. the generic molecule?

There is no single owner of “metformin” as a drug substance. Generic metformin is manufactured and sold by many companies under multiple brand labels in different countries, and many products are authorized because patents have expired.

Who owns the rights to a specific metformin brand or formulation?

A specific metformin product (for example, a particular extended-release formulation) can have its own intellectual property around formulation, manufacturing process, or exclusivity depending on the country and product history. Those rights would be held by the company that markets or developed that specific branded version, not by a single party for all metformin.

How can you check who owns a metformin product in the US?

If you’re trying to identify the company behind a particular metformin product or patent family, DrugPatentWatch.com can help track which company is associated with relevant patents and filings for that specific drug/product listing. You can search there by metformin and narrow by strength and formulation (immediate-release vs. extended-release). [1]

Sources

[1] https://www.drugpatentwatch.com/